(Q37157924)

18 August 2017

Collaborative evaluation in seven laboratories of a standardized micromethod for yeast susceptibility testing (English)

1 reference

18 August 2017

1 reference

Guinet R

1

1 reference

18 August 2017

Nerson D

2

1 reference

18 August 2017

de Closets F

3

1 reference

18 August 2017

Dupouy-Camet J

4

1 reference

18 August 2017

Kures L

5

1 reference

18 August 2017

Marjollet M

6

1 reference

18 August 2017

Poirot JL

7

1 reference

18 August 2017

Ros A

8

1 reference

18 August 2017

Texier-Maugein J

9

1 reference

18 August 2017

Volle PJ

10

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 November 1988

1 reference

Journal of Clinical Microbiology

18 August 2017

1 reference

18 August 2017

26

1 reference

18 August 2017

11

1 reference

18 August 2017

2307-2312

1 reference

Ketoconazole in the prevention of experimental candidal vaginitis

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266882

Disposition of ketoconazole, an oral antifungal, in humans

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266882

Clotrimazole (Bay b 5097): in vitro and clinical pharmacological studies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266882

Test methods for antifungal agents--a critical review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266882

Laboratory Evaluation of a Rapid, Automated Susceptibility Testing System: Report of a Collaborative Study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266882

Antifungal Activity of Tioconazole (UK-20,349), a New Imidazole Derivative

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266882

Prevention and mycoses in immunocompromised patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266882

In vitro antifungal susceptibility testing and measurement of levels of antifungal agents in body fluids.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266882

Miconazole: a preliminary review of its therapeutic efficacy in systemic fungal infections

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266882

Fatal septicemia due to amphotericin B-resistant Candida lusitaniae.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266882

Antifungal drug susceptibility testing. A critical review

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266882

Antifungal Agents Used in Systemic Mycoses Activity and Therapeutic Use

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266882

Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266882

Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266882

Influence of culture medium on susceptibility testing with BAY n 7133 and ketoconazole

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266882

Azole resistance in Candida albicans.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266882

The activity in vitro and in vivo of a new imidazole antifungal, ketoconazole

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266882

New azole compounds: vibunazole (Bay n7133) and Bay L9139, compared with ketoconazole in the therapy of systemic candidosis and in pharmacokinetic studies, in mice

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266882

Improved method for estimation of azole antifungal inhibitory concentrations against Candida species, based on azole/antibiotic interactions

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266882

Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitro

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266882

[Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod]

27 June 2018

1 reference

12 December 2020

Preliminary studies on the pharmacology and therapeutic activity of oral and intravenous econazole

1 reference

12 December 2020

[Multicenter study of the standardization of sensitivity testing of fungi to 5-fluorocytosine and amphotericin B]

1 reference

12 December 2020

Miconazole-resistant Candida

1 reference

12 December 2020

Laboratory evaluation of antifungal agents: a comparative study of five imidazole derivatives of clinical importance

1 reference

12 December 2020

An Evaluation of Two Years of Clinical Experience with Ketoconazole

1 reference

12 December 2020

Combination Therapy of Experimental Candidiasis, Cryptococcosis and Aspergillosis in Mice

1 reference

12 December 2020

Ketoconazole therapy for fungal urinary tract infections

1 reference

12 December 2020

Relative inhibition factors--a novel approach to the assessment of antifungal antibiotics in vitro

1 reference

12 December 2020

In-vitro resistance to imidazole antifungals in Candida albicans

1 reference

12 December 2020

Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal a

1 reference

12 December 2020

Correlation of susceptibility test results in vitro with response in vivo: ketoconazole therapy in a systemic candidiasis model

1 reference

12 December 2020

10.1128/JCM.26.11.2307-2312.1988

Identifiers

DOI

0 references

1 reference

18 August 2017

PubMed publication ID

3235657

1 reference